Filing Flows

Filing Flows › Companies › American Healthcare REIT › Timeline

American Healthcare REIT stock timeline

A year of the price with every insider trade, planned sale, earnings report and material 8-K marked

252 sessions+23.3% to $57.91

American Healthcare REIT (AHR) stock rose 23% over the last 252 sessions, to $57.91. On the way it reported 5 quarters, its insiders filed 3 open-market trades and 4 Form 144 notices of planned sales, and the company filed 7 material 8-Ks. Each is marked on the price and listed with what the stock did next.

AHR: a year of the stock with every disclosure on itAHR: a year of the stock with every disclosure on it$47.72$51.46$55.20$58.94●2025-11-06 · Earnings: beat the EPS estimate by 74.9%◆2026-02-04 · Directors and officers: departures, appointments, pay●2026-02-26 · Earnings: missed the EPS estimate by -6.3%◆2026-02-27 · Material definitive agreement◆2026-03-24 · Directors and officers: departures, appointments, pay◆2026-04-07 · Material definitive agreement●2026-05-07 · Earnings: missed the EPS estimate by -7.4%▼2026-06-24 · Foster Mark E. sold $121K▽2026-06-24 · Form 144: Mark Foster plans to sell $121K▼2026-06-26 · Peay Brian sold $1.3M▽2026-06-26 · Form 144: Brian Peay plans to sell $1.3M◆2026-07-22 · Directors and officers: departures, appointments, pay●2026-08-06 · Earnings: beat the EPS estimate by 11.5%◆2026-08-10 · Material definitive agreement▽2026-09-01 · Form 144: Mark Foster plans to sell $111K◆2026-09-02 · Directors and officers: departures, appointments, pay▼2026-09-25 · Foster Mark E. sold $78K▽2026-09-25 · Form 144: Mark Foster plans to sell $78K●2026-11-05 · Earnings: missed the EPS estimate by -16.8%●Earnings report◆8-K event▼Insider sale▽Planned sale (Form 144)2025-11-062026-11-06
Daily closes, Nov 6, 2025 to Nov 6, 2026; hover a mark for the filing.

Each mark, and what followed

DateKindWhatNext session5 sessions21 sessions
Nov 5, 2026EarningsEarnings: missed the EPS estimate by -16.8%−0.6% (+3.9% vs SPY)——
Sep 25, 2026Form 144Form 144: Mark Foster plans to sell $78K−0.6% (−1.1% vs SPY)−2.7% (−2.3% vs SPY)+1.8% (+2.8% vs SPY)
Sep 25, 2026Insider saleFoster Mark E. sold $78K−0.6% (−1.1% vs SPY)−2.7% (−2.3% vs SPY)+1.8% (+2.8% vs SPY)
Sep 2, 20268-KDirectors and officers: departures, appointments, pay−0.8% (−1.8% vs SPY)−3.9% (−2.9% vs SPY)−9.7% (−10.6% vs SPY)
Sep 1, 2026Form 144Form 144: Mark Foster plans to sell $111K+2.4% (+3.1% vs SPY)−1.1% (−1.0% vs SPY)−6.9% (−6.6% vs SPY)
Aug 10, 20268-KMaterial definitive agreement−5.1% (−4.8% vs SPY)−1.4% (−1.4% vs SPY)−3.1% (−1.7% vs SPY)
Aug 6, 2026EarningsEarnings: beat the EPS estimate by 11.5%−1.4% (−1.3% vs SPY)−5.4% (−5.7% vs SPY)+0.5% (0.0% vs SPY)
Jul 22, 20268-KDirectors and officers: departures, appointments, pay−1.2% (0.0% vs SPY)+0.8% (+3.2% vs SPY)−2.3% (−4.3% vs SPY)
Jun 26, 2026Form 144Form 144: Brian Peay plans to sell $1.3M+0.2% (+0.9% vs SPY)+8.3% (+6.9% vs SPY)+12.6% (+11.9% vs SPY)
Jun 26, 2026Insider salePeay Brian sold $1.3M+0.2% (+0.9% vs SPY)+8.3% (+6.9% vs SPY)+12.6% (+11.9% vs SPY)
Jun 24, 2026Form 144Form 144: Mark Foster plans to sell $121K+2.9% (+3.0% vs SPY)+7.4% (+5.6% vs SPY)+15.2% (+14.6% vs SPY)
Jun 24, 2026Insider saleFoster Mark E. sold $121K+2.9% (+3.0% vs SPY)+7.4% (+5.6% vs SPY)+15.2% (+14.6% vs SPY)
May 7, 2026EarningsEarnings: missed the EPS estimate by -7.4%−0.8% (−0.5% vs SPY)+3.1% (+2.0% vs SPY)−5.2% (−5.7% vs SPY)
Apr 7, 20268-KMaterial definitive agreement+1.7% (−0.8% vs SPY)+2.5% (−2.7% vs SPY)+5.0% (−5.8% vs SPY)
Mar 24, 20268-KDirectors and officers: departures, appointments, pay−0.6% (−1.2% vs SPY)−1.8% (−1.3% vs SPY)+5.2% (−2.9% vs SPY)
Feb 27, 20268-KMaterial definitive agreement+1.3% (+1.2% vs SPY)−1.4% (+0.6% vs SPY)−10.7% (−2.8% vs SPY)
Feb 26, 2026EarningsEarnings: missed the EPS estimate by -6.3%+0.5% (+1.1% vs SPY)−2.0% (−0.8% vs SPY)−11.0% (−4.1% vs SPY)
Feb 4, 20268-KDirectors and officers: departures, appointments, pay+2.8% (+4.1% vs SPY)+9.6% (+8.7% vs SPY)+9.5% (+11.6% vs SPY)
Nov 6, 2025EarningsEarnings: beat the EPS estimate by 74.9%+1.8% (+2.8% vs SPY)+1.6% (+0.8% vs SPY)+6.2% (+5.0% vs SPY)

Insiders’ record here

In the year on the chart, American Healthcare REIT's insiders reported 0 open-market buys ($0) and 3 sales ($1.5M). Of the 2 old enough to score, 2 were followed by the stock doing what the trade implied over the next 63 sessions (beating SPY after a buy, lagging it after a sale); the median excess return after a buy was — and after a sale −1.5%.

Across the whole universe (19,782 scored trades), insider buys beat the market 46% of the time and sales were followed by a lagging stock 61% of the time; buys of $1M or more 39%. Every pattern →

What this kind of 8-K usually did

Item8-KsNext session, medianUp next session21 sessions, medianTypical size
5.02 Directors and officers: departures, appointments, pay39,174−0.1%48%+0.7%±1.4%
1.01 Material definitive agreement23,5250.0%51%+1.0%±1.4%
2.03 New debt or off-balance-sheet obligation13,2680.0%50%+1.2%±1.3%

Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →

Report card: every quarter against the estimate → American Healthcare REIT: every quarter → Live insider trades →

Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.